Literature DB >> 28493059

Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas.

Michelle Kim1, Perri Deacon1, Rommel G Tirona1, Richard B Kim1,2,3, Christopher L Pin1,3,4, Henriette E Meyer Zu Schwabedissen5, Rennian Wang1,2, Ute I Schwarz6,7,8.   

Abstract

Organic anion-transporting polypeptides (OATPs) are membrane proteins that mediate cellular uptake of structurally diverse endogenous and exogenous compounds, including bile salts, thyroid and sex hormones, pharmacological agents, and toxins. Roles of OATPs in human liver are well established. Our recent report suggested the presence of the hepatic transporter OATP1B3 in human β cells. The aim of this study was to better characterize cellular localization and interindividual variation in OATP1B3 expression in human adult islets as a function of age, sex, and pancreatic disease, and to assess the expression of other OATPs. High transcript levels of OATP1B3, OATP2B1, OATP1A2, but not OATP1B1 were observed in isolated human adult islets. While OATP1B3 protein expression was variable, the carrier co-localized more frequently with glucagon-positive α cells than insulin-positive β cells in islets of normal pancreatic tissues from ten subjects using dual immunostaining. Moreover, OATP1B3 co-staining with endocrine cells was two- to three-fold higher in older (≥60 years) than younger (<60 years) subjects. In comparison, in a subset of three individuals, OATP2B1 was primarily found in β cells, suggesting a distinct expression pattern for OATP1B3 and OATP2B1 in islets. Abundant OATP1B3 staining was also observed in islet as well as ductal cells of diseased tissues of patients with pancreatitis or pancreatic adenocarcinoma. Considering the abundance of key OATP carriers in β and α cells, potential implications of OATP transport in islet cell function may be suggested. Future studies are needed to gain insights into their specific endocrine roles as well as pharmacological relevance.

Entities:  

Keywords:  Human pancreas; Insulin secretion; Islet; Membrane transporters; Organic anion transport protein

Mesh:

Substances:

Year:  2017        PMID: 28493059     DOI: 10.1007/s00418-017-1580-6

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  52 in total

Review 1.  Functions of OATP1A and 1B transporters in vivo: insights from mouse models.

Authors:  Dilek Iusuf; Evita van de Steeg; Alfred H Schinkel
Journal:  Trends Pharmacol Sci       Date:  2011-11-28       Impact factor: 14.819

2.  High-throughput real-time PCR.

Authors:  Thomas D Schmittgen; Eun Joo Lee; Jinmai Jiang
Journal:  Methods Mol Biol       Date:  2008

3.  Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20.

Authors:  M M Byrne; J Sturis; S S Fajans; F J Ortiz; A Stoltz; M Stoffel; M J Smith; G I Bell; J B Halter; K S Polonsky
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

4.  The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides.

Authors:  Michiaki Abe; Takafumi Toyohara; Akiko Ishii; Takehiro Suzuki; Naoya Noguchi; Yasutoshi Akiyama; Hiromi O Shiwaku; Rie Nakagomi-Hagihara; Guodong Zheng; Eisuke Shibata; Tomokazu Souma; Tomohiko Shindo; Hirohito Shima; Yoichi Takeuchi; Eikan Mishima; Masayuki Tanemoto; Tetsuya Terasaki; Tohru Onogawa; Michiaki Unno; Sadayoshi Ito; Shin Takasawa; Takaaki Abe
Journal:  Drug Metab Pharmacokinet       Date:  2010       Impact factor: 3.614

Review 5.  SLC transporters as therapeutic targets: emerging opportunities.

Authors:  Lawrence Lin; Sook Wah Yee; Richard B Kim; Kathleen M Giacomini
Journal:  Nat Rev Drug Discov       Date:  2015-06-26       Impact factor: 84.694

6.  Pancreatic and Islet Development and Function: The Role of Thyroid Hormone.

Authors:  Teresa L Mastracci; Carmella Evans-Molina
Journal:  J Endocrinol Diabetes Obes       Date:  2014

7.  Human skeletal muscle drug transporters determine local exposure and toxicity of statins.

Authors:  Michael J Knauer; Bradley L Urquhart; Henriette E Meyer zu Schwabedissen; Ute I Schwarz; Christopher J Lemke; Brenda F Leake; Richard B Kim; Rommel G Tirona
Journal:  Circ Res       Date:  2009-11-25       Impact factor: 17.367

8.  The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction.

Authors:  Kacey J Prentice; Lemieux Luu; Emma M Allister; Ying Liu; Lucy S Jun; Kyle W Sloop; Alexandre B Hardy; Li Wei; Weiping Jia; I George Fantus; Douglas H Sweet; Gary Sweeney; Ravi Retnakaran; Feihan F Dai; Michael B Wheeler
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

9.  β-cell mass and turnover in humans: effects of obesity and aging.

Authors:  Yoshifumi Saisho; Alexandra E Butler; Erica Manesso; David Elashoff; Robert A Rizza; Peter C Butler
Journal:  Diabetes Care       Date:  2012-08-08       Impact factor: 19.112

Review 10.  Glucagon-like peptide-1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesity.

Authors:  Amelia K Linnemann; Dawn Belt Davis
Journal:  J Diabetes Investig       Date:  2016-03-14       Impact factor: 4.232

View more
  2 in total

Review 1.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

Review 2.  The Roles of Thyroid and Thyroid Hormone in Pancreas: Physiology and Pathology.

Authors:  Chaoran Chen; Zhenxing Xie; Yingbin Shen; Shu Fang Xia
Journal:  Int J Endocrinol       Date:  2018-06-14       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.